Analysis at the intersection of intellectual
property law and the public interest.
Urs Gasser and Wolfgang Schulz Berkman Center Research Publication No. 2015-5 February 2015 | Full Text (SSRN) A. Summary A review of online intermediary governance frameworks and issues in Brazil, the European Union, India, South Korea, the United States, Thailand, Turkey, and Vietnam creates a picture full of nuance, whether looking at the genesis of […]
LDCs Members have submitted a duly motivated request for an unconditional extension of the 2002-2016 pharmaceutical transition period (covering patents and data) and for relief from the requirements of TRIPS Article 70.8 and 70.9 (mailbox and marketing exclusivity provisions). This expert analysis confirm LDCs’ need and entitlement to the requested extension. Professor Brook K. Baker[1] […]
Report by Ethan Senack for the Student PIRGs Full report here, (CC-BY) Executive Summary: According to the College Board, the average undergraduate student should budget between $1,200 and $1,300 for textbooks and supplies each year. That’s as much as 40% of tuition at a two-year community college and 13% at a four-year public institution. For […]
Company joins five other MPP patent holders in efforts to improve HIV paediatric care [Reposted from the Medicines Patent Pool, Link, (CC-BY-NC-ND)] The Medicines Patent Pool (MPP) announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with […]
I am writing to you as part of the International Policy team at the Washington-based digital rights group, Public Knowledge, to alert you to a free and open Spanish-language online course called “Open Internet” (Internet Abierto Y Libre) that we are launching early March 2015. This course may be of interest to you, your students, […]
Authors: Christine Årdal, John-Arne Røttingen Abstract: Greater investment is required in developing new drugs and vaccines against malaria in order to eradicate malaria. These precious funds must be carefully managed to achieve the greatest impact. We evaluate existing efforts to discover and develop new drugs and vaccines for malaria to determine how best malaria R&D […]
